{"entity":{"type":"insider","cik":"0002015536","url":"/insider/0002015536","json_url":"/insider/0002015536.json","name":"Deep Track Biotechnology Master Fund, Ltd.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":3,"first":"2024-05-13","last":"2025-09-16","span_basis":"filed_date"},"name_variants":[{"name":"Deep Track Biotechnology Master Fund, Ltd.","source":"filing","n_filings":3,"first_seen":"2024-05-13","last_seen":"2025-09-16"}],"transactions":[{"id":4646102,"accession":"0002015536-25-000007","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0002015536-25-000007","line_url":"/filing/0002015536-25-000007","is_derivative":false,"issuer_cik":"0001397513","issuer_name":"LB PHARMACEUTICALS INC","issuer_ticker":"LBRX","issuer_name_source":null,"issuer_url":"/issuer/0001397513","owner_cik":null,"owner_name":"Deep Track Capital, LP; KROIN DAVID","owner_display_name":"Deep Track Capital, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2666666.0,"shares_display":"2,666,666","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":39999990.0,"total_display":"39,999,990.00","total_whole":"39,999,990","shares_owned_after":2686138.0,"shares_owned_after_display":"2,686,138","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-12","filed_date":"2025-09-16","scope":"insider","n_lines":2},{"id":4528068,"accession":"0000950170-25-111070","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-111070","line_url":"/filing/0000950170-25-111070#line-2","is_derivative":false,"issuer_cik":"0001029142","issuer_name":"DYNAVAX TECHNOLOGIES CORP","issuer_ticker":"DVAX","issuer_name_source":null,"issuer_url":"/issuer/0001029142","owner_cik":null,"owner_name":"Deep Track Biotechnology Master Fund, Ltd.; Deep Track Capital, LP; KROIN DAVID","owner_display_name":"Deep Track Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":970143.0,"shares_display":"970,143","price_per_share":10.59,"price_display":"10.59","price_state":"stated","total_value":10273814.37,"total_display":"10,273,814.37","total_whole":"10,273,814","shares_owned_after":15726349.0,"shares_owned_after_display":"15,726,349","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-22","filed_date":"2025-08-22","scope":"insider"},{"id":4528060,"accession":"0000950170-25-111070","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-111070","line_url":"/filing/0000950170-25-111070#line-1","is_derivative":false,"issuer_cik":"0001029142","issuer_name":"DYNAVAX TECHNOLOGIES CORP","issuer_ticker":"DVAX","issuer_name_source":null,"issuer_url":"/issuer/0001029142","owner_cik":null,"owner_name":"Deep Track Biotechnology Master Fund, Ltd.; Deep Track Capital, LP; KROIN DAVID","owner_display_name":"Deep Track Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1094994.0,"shares_display":"1,094,994","price_per_share":11.03,"price_display":"11.03","price_state":"stated","total_value":12077783.82,"total_display":"12,077,783.82","total_whole":"12,077,784","shares_owned_after":16696492.0,"shares_owned_after_display":"16,696,492","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-21","filed_date":"2025-08-22","scope":"insider"},{"id":2141675,"accession":"0000950170-24-058720","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-058720","line_url":"/filing/0000950170-24-058720#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":null,"owner_name":"Deep Track Biotechnology Master Fund, Ltd.; Deep Track Capital, LP; KROIN DAVID","owner_display_name":"Deep Track Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56000.0,"shares_display":"56,000","price_per_share":1.7791,"price_display":"1.78","price_state":"stated","total_value":99629.6,"total_display":"99,629.60","total_whole":"99,630","shares_owned_after":18344000.0,"shares_owned_after_display":"18,344,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-10","filed_date":"2024-05-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001691082","name":"LB PHARMACEUTICALS INC","url":"/issuer/0001691082","role":"Ten percent owner","n_filings":1,"first_seen":"2025-09-16","last_seen":"2025-09-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001029142","name":"DYNAVAX TECHNOLOGIES CORP","url":"/issuer/0001029142","role":"Ten percent owner","n_filings":1,"first_seen":"2025-08-22","last_seen":"2025-08-22"},{"type":"issuer","type_label":"ISSUER","cik":"0000906709","name":"NEKTAR THERAPEUTICS","url":"/issuer/0000906709","role":"Ten percent owner","n_filings":1,"first_seen":"2024-05-13","last_seen":"2024-05-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002015536","retrieved_at":"2026-08-22T06:15:49+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}